Ad is loading...
MENU
MIRM
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Mirum Pharmaceuticals (MIRM) Ownership - Who owns Mirum Pharmaceuticals?
Profile
Industry
N/A
Address
950 Tower Lane
Phone
+1 650 667-4085
Employees
264
Web
https://www.mirumpharma.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
2.12B
P/E Ratio
N/A
Total Cash
278.37M
Projected Growth
N/A
Total Debt
316.56M
Revenue
264.38M
Risk (Beta)
0.59
Dividend Yield
N/A
Total Cash/Share
5.83
Total Debt/Equity
N/A
Revenue/Share
7.23 USD as % of share price
Fundamentals
MIRM
Capitalization
2.12B
P/E Ratio
N/A
Risk (Beta)
0.59
Dividend Yield
N/A
Total Cash
278M
Total Cash/Share
5.83
Total Debt
317M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
7.23%
Revenue
264M
ROE
N/A
Book Value
229M
P/B Ratio
9.21
Cash Flow
N/A
Earnings
-2.31
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
5K
Current Ratio
3.28
Current Revenue Per Employee
264880.94
Dividends Per Share - Security
N/A
EBITDA
-73.47M
Float
N/A
Float - Current
N/A
Gross Income Margin
74.03
Revenue To Assets
-19.77
Shares Held By Institutions
3.29B
Shares Outstanding - Current
47.7M
Total Liabilities
432M
Total Volume MTD
N/A
Value
-1
Gain YTD
50.745
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a biopharmaceutical company. which focuses on the development and commercialization of a late-stage pipeline of novel therapies for debilitating liver diseases.
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
950 Tower Lane
Phone
+1 650 667-4085
Employees
264
Web
https://www.mirumpharma.com